Circulating Hepatitis B Virus (HBV) RNA and Conventional Markers in Treatment-Naive Persons With HBV in Senegal
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf190 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Lorin Begré und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: RNA, Viral, Hepatitis B virus, Hepatitis B, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hepatitis B virus (HBV) infection affects approximately 10% of the general population in West Africa. Circulating HBV RNA may help improve the characterization of HBV disease and prognosis. We aimed to evaluate the associations between HBV RNA and conventional biomarkers of HBV replication in the Senegalese Hepatitis B Cohort Study (SEN-B).
Methods
We included all treatment-naive, human immunodeficiency virus–negative participants of SEN-B with chronic HBV infection confirmed by a quantitative hepatitis B surface antigen (HBsAg) >0.05 IU/mL. We quantified HBV RNA, HBV DNA, and HBsAg levels and evaluated associations between those markers stratified by HBV infection phase, alanine aminotransferase level, and liver fibrosis stage.
Results
Of 719 participants, 17 (2.4%) were hepatitis B e antigen (HBeAg)-positive (EP), 620 (86.2%) were classified as HBeAg-negative chronic infection (ENCI), and 82 (11.4%) were classified as HBeAg-negative chronic hepatitis (ENCH). HBV RNA was undetectable in 361 (49.8%) participants, and detectable but unquantifiable in 188 (26.1%). HBV RNA levels correlated moderately with HBV DNA levels in EP (ρ = 0.58, P = .01) and ENCH (ρ = 0.54, P < .001) and weakly in ENCI (ρ = 0.39, P < .001). HBsAg levels were only significantly correlated with HBV RNA levels in the ENCH group (ρ = −0.22, P = .05). In multivariable logistic regression, HBV RNA levels and HBV RNA to HBV DNA ratio were independently associated with significant liver fibrosis.
Conclusions
In our cohort of treatment-naive persons with HBV from Senegal, approximately 50% had undetectable HBV RNA levels. HBV RNA levels correlated with HBV DNA but not HBsAg levels in all phases of HBV infection and may provide an additional tool to assess HBV disease phase and activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
- Centre Régional de Recherche et de Formation à la Prise en Charge Clinique, Fann University Hospital, Dakar, Senegal.
- Service des Maladies Infectieuses et Tropicales, Fann University Hospital, Dakar, Senegal.
- Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
- Interregional Blood Transfusion Swiss Red Cross, Bern, Switzerland.
- Centre de Traitement Ambulatoire, Fann University Hospital, Dakar, Senegal.
ORCID-Profile: Lorin Begré, Bruce S Wembulua, Ousseynou Ndiaye, Pascal Bittel, Christoph Niederhauser, Andri Rauch, Ndeye Fatou Ngom, Adrià Ramírez Mena, Gilles Wandeler, Moussa Seydi
Zitieren
APA
Begré, L., Akotia, M. K., Wembulua, B. S., Pandi, M., Ndiaye, O., Tine, J., Bittel, P., Niederhauser, C., Stolz, M., Rauch, A., Ngom, N. F., Ramírez Mena, A., Wandeler, G., Seydi, M., & Senegalese Hepatitis B Cohort Study (SEN-B) (2025). Circulating Hepatitis B Virus (HBV) RNA and Conventional Markers in Treatment-Naive Persons With HBV in Senegal. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf190
Vancouver
Begré L, Akotia MK, Wembulua BS, Pandi M, Ndiaye O, Tine J, et al. Circulating Hepatitis B Virus (HBV) RNA and Conventional Markers in Treatment-Naive Persons With HBV in Senegal. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf190
BibTeX
@article{Begr2025,
author = {Begré, Lorin and Akotia, Messan K and Wembulua, Bruce S and Pandi, Melissa and Ndiaye, Ousseynou and Tine, Judicaël and Bittel, Pascal and Niederhauser, Christoph and Stolz, Martin and Rauch, Andri and Ngom, Ndeye Fatou and Ramírez Mena, Adrià and Wandeler, Gilles and Seydi, Moussa and Senegalese Hepatitis B Cohort Study (SEN-B), Senegalese Hepatitis B Cohort Study (SEN-B)},
title = {Circulating Hepatitis B Virus (HBV) RNA and Conventional Markers in Treatment-Naive Persons With HBV in Senegal},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf190}
}
EUVIMED